StockData
Lantern Pharma Inc. logo

Lantern Pharma Inc. (LTRN) stock

LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 5/30
$0.36−0.02 (-6.17%)

Close on Nov 17, 2026Market cap $4.67MP/E –Yield –

Lantern Pharma total assets

Total assets on the balance sheet at the end of each period.

Lantern Pharma's total assets was $8.52M at Sep 30, 2026. For fiscal 2025 it was $11.04M, down 56.8% from the year before. The highest annual figure on record is $73.95M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.04M-56.8%
FY2024Dec 31, 2024$25.57M-41.4%
FY2023Dec 31, 2023$43.65M-25.8%
FY2022Dec 31, 2022$58.84M-20.4%
FY2021Dec 31, 2021$73.95M+263.2%
FY2020Dec 31, 2020$20.36M+1321.2%
FY2019Dec 31, 2019$1.43M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.52M-37.4%
Q2 FY2026Jun 30, 2026$8.60M-50.6%
Q1 FY2026Mar 31, 2026$7.22M-65.8%
Q4 FY2025Dec 31, 2025$11.04M-56.8%
Q3 FY2025Sep 30, 2025$13.63M-55.0%
Q2 FY2025Jun 30, 2025$17.42M-51.0%
Q1 FY2025Mar 31, 2025$21.10M-46.9%
Q4 FY2024Dec 31, 2024$25.57M-41.4%
Q3 FY2024Sep 30, 2024$30.29M-36.6%
Q2 FY2024Jun 30, 2024$35.59M-30.8%
Q1 FY2024Mar 31, 2024$39.73M-28.4%
Q4 FY2023Dec 31, 2023$43.65M-25.8%
Q3 FY2023Sep 30, 2023$47.77M-23.2%
Q2 FY2023Jun 30, 2023$51.43M-22.5%
Q1 FY2023Mar 31, 2023$55.51M-18.8%
Q4 FY2022Dec 31, 2022$58.84M-20.4%
Q3 FY2022Sep 30, 2022$62.16M-19.9%
Q2 FY2022Jun 30, 2022$66.38M-19.5%
Q1 FY2022Mar 31, 2022$68.40M-17.1%
Q4 FY2021Dec 31, 2021$73.95M+263.2%
Q3 FY2021Sep 30, 2021$77.61M+245.0%
Q2 FY2021Jun 30, 2021$82.43M+221.8%
Q1 FY2021Mar 31, 2021$82.50M+5659.2%
Q4 FY2020Dec 31, 2020$20.36M–
Q3 FY2020Sep 30, 2020$22.49M–
Q2 FY2020Jun 30, 2020$25.61M–
Q4 FY2019Dec 31, 2019$1.43M–

More Lantern Pharma figures

See a number that looks wrong?